
Sign up to save your podcasts
Or


Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now have to grapple with.
Be sure to go to boardsbank.com! Free rheumatology board review, >1000 questions!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2602567
By Michael Putman4.9
114114 ratings
Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now have to grapple with.
Be sure to go to boardsbank.com! Free rheumatology board review, >1000 questions!
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2602567

506 Listeners

299 Listeners

124 Listeners

3,360 Listeners

1,152 Listeners

120 Listeners

197 Listeners

517 Listeners

68 Listeners

4 Listeners

373 Listeners

182 Listeners

188 Listeners

17 Listeners

6 Listeners